Old Web
English
Sign In
Acemap
>
authorDetail
>
I-Yuan (Cathy) Liu
I-Yuan (Cathy) Liu
ACADIA Pharmaceuticals Inc.
Pimavanserin
Psychology
Psychiatry
Schizophrenia
antipsychotic treatment
3
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis
2020
Parkinsonism & Related Disorders
Clive Ballard
David L. Kreitzman
Stuart Isaacson
I-Yuan (Cathy) Liu
James C. Norton
George Demos
Hubert H. Fernandez
Tihomir V. Ilić
Jean-Philippe Azulay
Joaquim J. Ferreira
Victor Abler
Srdjan Stankovic
Show All
Source
Cite
Save
Citations (5)
T42. HIGH ADHERENCE TO CURRENT ANTIPSYCHOTIC AND ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL TO EVALUATE THE TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT
2020
Schizophrenia Bulletin
Brandon Abbs
Dragana Bugarski-Kirola
I-Yuan (Cathy) Liu
Mona Darwish
Srdjan Stankovic
Show All
Source
Cite
Save
Citations (1)
T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT
2020
Schizophrenia Bulletin
Dragana Bugarski-Kirola
Rene Nunez
Ramzey Odetalla
Mohammed A Bari
István Bitter
Peter D Feldman
I-Yuan (Cathy) Liu
Srdjan Stankovic
Show All
Source
Cite
Save
Citations (1)
1